Global Liver Institute

During the 79th World Health Assembly (WHA79) in , Global Liver Institute, in collaboration with the Ministry of Health & Population of Egypt, convened global leaders and stakeholders to advance collaboration across , metabolic health, and non-communicable disease policy.

The ministerial panel brought together representatives from , , , , , , and to explore how coordinated action can strengthen prevention, early detection, and care for steatotic and related conditions.

As liver and metabolic diseases continue to rise worldwide, this dialogue reinforced a shared global commitment to driving implementation of the WHA resolution on steatotic liver disease, turning policy recognition into concrete action.

At just 8 months old, Hannah Fleming received a life-saving after being diagnosed with , a condition that required her to receive a new as an infant. Nearly three decades later, she is now caring for transplant patients as a nurse on the same team that helps others through their own journeys.

Growing up, Hannah learned about her transplant history and the impact of donation from her family, which inspired her to pursue a career in nursing. Today, she uses her own experience as a transplant recipient to support patients facing the same uncertainty and emotions she once knew.

For Hannah, caring for transplant is a reminder of the journey that shaped her life. Through her work, advocacy for organ donation and upcoming participation in the New York City Marathon supporting the American Liver Foundation , she continues to honor the donor and family who gave her a second chance.

https://people.com/woman-who-received-liver-transplant-as-baby-now-a-nurse-on-liver-transplant-team-exclusive-11962922

Woman Who Received a Liver Transplant as a Baby Is Now a Nurse on a Transplant Team: ‘What I Was Meant to Do’ (Exclusive) Hannah Fleming received a life-saving liver transplant when she was 8 months old due to biliary atresia. Now, she is a registered nurse working on a transplant team, Fleming shared in an exclusive interview with PEOPLE.

GLI is proud to welcome Biliary Atresia Liver Care Africa (BALCA) to the Liver Action Network (LAN)!

BALCA’s work supporting children and families affected by and across reflects the kind of patient-driven advocacy that strengthens the global .

As LAN continues to expand, partnerships like these help strengthen our collective ability to elevate patient voices, share expertise, and drive meaningful progress in worldwide.

Last month, at the 79th World Health Assembly in , Global Liver Institute, in collaboration with the Ministry of Health and Population of , brought together global health leaders, policymakers, advocates, and partners to advance a shared vision: making steatotic [fatty] liver disease (SLD), a recognized priority within the global non-communicable disease agenda.

Through meaningful conversations on implementation, policy, prevention, patient engagement, and cross-sector collaboration, the discussions emphasized the importance of coordinated action to address the growing burden of SLD and metabolic challenges worldwide.

Building on the momentum of the WHA resolution on SLD, the conversations in Geneva marked a critical shift from awareness to action, reinforcing that the path forward must prioritize implementation, accountability, and sustained collaboration.

Read the full recap and key highlights here: https://globalliver.org/together-for-steatotic-liver-disease-the-hidden-ncds-sld-as-the-next-global-public-health-priority/

Today, we celebrate and father figures everywhere.
Thank you for the strength, care, and guidance you bring to families and communities every day.
This Fathersday, take a moment to check in on your health, your matters, too.

GLI is headed to ! 🌎

Joel Ballew will be representing Global Liver Institute at the BIO International Convention in San Diego.

We’re looking forward to connecting with innovators and partners who are working to transform today’s discoveries into better outcomes for patients around the world.

On Global , Dr. Jackie Kassouf Maalouf, President of and Vice President of the International Diabetes Federation, joined an international expert panel discussing steatotic (fatty) liver disease, the most common chronic liver condition worldwide. The webinar highlighted major developments in the field, including advances in diagnosis, treatment, policy, and the growing recognition of the links between , , , disease, and other non-communicable diseases ( ).

A key focus of the discussion was the recent adoption of the World Health Assembly Resolution on liver disease, a historic milestone that recognizes steatotic liver disease as a major global metabolic health challenge. As Dr. Maalouf emphasized, the resolution marks a critical starting point, with its success depending on stronger awareness, early detection, equitable access to care, and integrated systems that address metabolic health holistically.

A long-standing supporter of Global Liver Institute's Global Fatty Liver Day campaign, DiaLeb remains committed to raising awareness of the connection between diabetes and health and advancing people-centered approaches to , , and care.

📹

Global State of Steatotic (Fatty) Liver Disease Steatotic (fatty) liver disease is now the most common chronic live...

"It’s just fatty liver."

📣 Dianne heard those words too many times.

Years of missed symptoms, weight bias, and delayed follow-up ultimately led to a stage 4 liver disease diagnosis. Now, she's sharing her story to help others feel seen, heard, and taken seriously sooner. ❤️

✍️In her latest guest column, Dianne reflects on the warning signs that were missed, the stigma surrounding liver disease, and why awareness, early screening, and compassion matter.

🔗Take a deeper dive here: https://bit.ly/4xDuDj0

Are you ready? 🚦
On July 1, the landscape of obesity care will change significantly with the launch of the CMS.gov GLP-1 Bridge program. This program introduces a brand-new, affordable pathway for eligible Medicare beneficiaries to access modern obesity treatments. However, with nationwide awareness currently low, medical providers and pharmacists must lead the way. Patient access depends entirely on whether clinical teams understand how to navigate this new model ahead of launch day. You can make the difference. It’s time to prepare so you can confidently have the conversation with your patients.

Join the Obesity Care Advocacy Network (OCAN), American Diabetes Association , Obesity Action Coalition - OAC, Obesity Medicine Association, American Society for Metabolic and Bariatric Surgery (ASMBS), and The Obesity Society for an essential national briefing:

🗓️ Date: June 18th
⏰ Times: 12:00 PM ET or 7:00 PM ET (Featuring a live evening Q&A for daytime clinicians!)
🚀 Title: “The BRIDGE to a Healthier You: Navigating the New Medicare GLP-1 Access”

🔗 Register today to secure your spot: https://obesitycareadvocacynetwork.com/bridgewebinar

We’re proud to welcome the American Liver Foundation to to the Liver Action Network ( )! As a leading voice in liver disease education, patient support, and research advocacy, your work continues to drive national awareness and progress in liver health.